Since the data here showed CAERS and/or CFEZO treatments upregulated expression level of Noxa, therefore, these treatments might represent a promising strategy to increase the therapeutic efficacy of ABT-737 to induce apoptosis in GBM. Here, PMAIP1 is linked to glioblastoma.